Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$1.16
-0.0600 (-4.92%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.90 $1.74 Friday, 10th May 2024 FGEN stock ended at $1.16. This is 4.92% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.04% from a day low at $1.12 to a day high of $1.21.
90 days $0.90 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Jun 01, 2016 $18.68 $18.96 $18.18 $18.89 387 912
May 31, 2016 $18.45 $18.85 $18.23 $18.66 669 753
May 27, 2016 $18.39 $18.49 $18.00 $18.43 317 318
May 26, 2016 $18.60 $18.64 $18.34 $18.39 309 208
May 25, 2016 $18.22 $18.72 $17.99 $18.52 566 584
May 24, 2016 $18.22 $18.39 $17.76 $18.20 919 522
May 23, 2016 $18.19 $18.60 $17.88 $17.98 410 655
May 20, 2016 $17.60 $18.09 $17.27 $18.04 310 199
May 19, 2016 $17.94 $18.47 $17.15 $17.50 294 226
May 18, 2016 $17.25 $18.26 $17.25 $17.95 327 602
May 17, 2016 $17.56 $18.02 $17.00 $17.35 344 914
May 16, 2016 $17.53 $18.23 $17.00 $17.60 469 478
May 13, 2016 $17.04 $17.75 $17.04 $17.49 344 870
May 12, 2016 $17.66 $17.97 $17.02 $17.11 490 633
May 11, 2016 $17.80 $18.52 $17.41 $17.45 391 131
May 10, 2016 $17.00 $18.27 $17.00 $17.94 834 432
May 09, 2016 $16.00 $16.95 $16.00 $16.73 581 710
May 06, 2016 $16.00 $16.38 $15.21 $15.79 624 824
May 05, 2016 $16.62 $17.02 $16.09 $16.22 362 748
May 04, 2016 $16.98 $17.01 $16.40 $16.55 483 107
May 03, 2016 $18.24 $18.55 $17.04 $17.15 431 319
May 02, 2016 $18.18 $18.45 $17.66 $18.37 395 079
Apr 29, 2016 $18.79 $19.09 $17.85 $18.00 479 055
Apr 28, 2016 $19.36 $19.48 $18.64 $18.77 379 524
Apr 27, 2016 $19.82 $20.05 $19.00 $19.21 292 270
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT